Microbiological Status of Venous Leg Ulcers and Its Predictors: A Single-Center Cross-Sectional Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Analyzed Clinicodemographic Parameters
2.2. Microbiological Examination
- −
- Shaking the tip of the swab in the phosphate-buffered saline solution;
- −
- A series of dilutions in a TSB (tryptone soya broth) medium;
- −
- Inoculation of 100 μL on the media:
- Sheep Blood Agar;
- Sabouraud Glucose Agar;
- MacConkey Agar;
- Bile Esculin Azide Agar;
- −
- The residual solution inoculated on CHROMagar Orientation;
- −
- Incubation for 1 day at 37 °C;
- −
- Interpretation of the results of microbial culture:
- Positive if >3.7 × 104 CFU/cm2;
- Positive regardless of CFU/cm2 if Pseudomonas aeruginosa or Streptococcus pyogenes beta-haemolyticus were detected.
2.3. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Limitation and Strength
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- O’Donnell, T.F.; Passman, M.A.; Marston, W.A.; Ennis, W.J.; Dalsing, M.; Kistner, R.L.; Lurie, F.; Henke, P.K.; Gloviczki, M.L.; Eklöf, B.G.; et al. Management of venous leg ulcers: Clinical practice guidelines of the Society for Vascular Surgery® and the American Venous Forum. J. Vasc Surg. 2014, 60 (Suppl. 2), 3S–59S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nelson, E.A.; Adderley, U. Venous leg ulcers. BMJ Clin. Evid. 2016, 15, 1902. [Google Scholar]
- Probst, S.; Weller, C.D.; Bobbink, P.; Saini, C.; Pugliese, M.; Skinner, M.B.; Gethin, G. Prevalence and incidence of venous leg ulcers—A protocol for a systematic review. Syst. Rev. 2021, 10, 148. [Google Scholar] [CrossRef] [PubMed]
- Finlayson, K.J.; Parker, C.N.; Miller, C.; Gibb, M.; Kapp, S.; Ogrin, R.; Anderson, J.; Coleman, K.; Smith, D.; Edwards, H.E. Predicting the likelihood of venous leg ulcer recurrence: The diagnostic accuracy of a newly developed risk assessment tool. Int. Wound J. 2018, 15, 686–694. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jockenhöfer, F.; Chapot, V.; Weindorf, M.S.; Körber, A.; Klode, J.; Buer, J.; Küpper, B.; Roesch, A.; Dissemond, J. Bacterial spectrum colonizing chronic leg ulcers: A 10-year comparison from a German wound care center. J. Dtsch. Dermatol. Gesellschaft. 2014, 12, 1121–1127. [Google Scholar] [CrossRef] [PubMed]
- Landis, S.J. Chronic wound infection and antimicrobial use. Adv. Ski. Wound Care. 2008, 21, 531–540. [Google Scholar] [CrossRef] [PubMed]
- Wounds UK. Best Practice Statement: Holistic Management of Venous leg Ulceration; Wounds UK: London, UK, 2016; Available online: www.wounds-uk.com (accessed on 10 December 2020).
- Garcia, T.F.; Borges, E.L.; Junho, T.O.C.; Spira, J.A.O. Microbiological profile of leg ulcer infections: Review study. Rev. Bras. Enferm. 2021, 74, e20190763. [Google Scholar] [CrossRef]
- Tuttle, M.S. Association between Microbial Bioburden and Healing Outcomes in Venous Leg Ulcers: A Review of the Evidence. Adv. Wound Care 2015, 4, 1–11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ambrosch, A.; Lobmann, R.; Pott, A.; Preissler, J. Interleukin-6 concentrations in wound fluids rather than serological markers are useful in assessing bacterial triggers of ulcer inflammation. Int. Wound J. 2008, 5, 99–106. [Google Scholar] [CrossRef]
- Høgsberg, T.; Bjarnsholt, T.; Thomsen, J.S.; Kirketerp-Møller, K. Success rate of split-thickness skin grafting of chronic venous leg ulcers depends on the presence of Pseudomonas aeruginosa: A retrospective study. PLoS ONE 2011, 6, e20492. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schmidt, K.; Debus, E.S.; Jessberger, S.; Ziegler, U.; Thiede, A. Bacterial population of chronic crural ulcers: Is there a difference between the diabetic, the venous, and the arterial ulcer? Vasa 2000, 29, 62–70. [Google Scholar] [CrossRef] [PubMed]
- Martins, M.A.; Santos, S.L.V.; Leão, L.S.; Araújo, N.P.; Bachion, M.M. Prevalence of resistance phenotypes in Staphylococcus aureus and coagulase-negative isolates of venous ulcers of primary healthcare patients. Rev. Soc. Bras. Med. Trop. 2012, 45, 717–722. [Google Scholar] [CrossRef] [Green Version]
- Dos Santos, S.D.; Martins, M.A.; do Prado, M.A.; Soriano, J.V.; Bachion, M.M. Gram-negative rods in venous ulcers and implications for primary care nursing care. Rev. Eletronica Enferm. 2014, 16, 370–377. [Google Scholar]
- Sopata, M.; Kucharzewski, M.; Tomaszewska, E. Antiseptic with modern wound dressings in the treatment of venous leg ulcers: Clinical and microbiological aspects. J. Wound Care 2016, 25, 419–426. [Google Scholar] [CrossRef] [PubMed]
- Hansson, C.; Hoborn, J.; Möller, A.; Swanbeck, G. The microbial flora in venous leg ulcers without clinical signs of infection. Acta Derm. Venereol. 1995, 75, 24–30. [Google Scholar] [CrossRef] [PubMed]
- Kingsley, A. A proactive approach to wound infection. Nurs. Standard. 2001, 15, 50–58. [Google Scholar] [CrossRef]
- Brook, I.; Frazier, E.H. Aerobic and anaerobic microbiology of chronic venous ulcers. Int. J. Dermatol. 1998, 37, 426–428. [Google Scholar] [CrossRef] [PubMed]
- EWMA. Position Document: Identifying Criteria for Wound Infection. European Wound Management Association. Available online: http://ewma.org/resources/for-professionals/ewma-documents-and-joint-publications/ewma-position-documents-2002-2008/ (accessed on 15 June 2019).
- Gardner, S.E.; Frantz, R.A.; Saltzman, C.L.; Dodgson, K.J. Staphylococcus aureus is associated with high microbial load in chronic wounds. Wounds 2004, 16, 251–257. [Google Scholar]
- Cooper, R.A. Understanding Wound Infection. European Wound Management Association (EWMA). In Position Document: Management of Wound Infection; MEP Ltd.: London, UK, 2006; pp. 2–5. [Google Scholar]
- Cooper, R.A.; Ameen, H.; Price, P.; McCulloch, D.A.; Harding, K.G. A clinical investigation into the microbiological status of ’locally infected’ leg ulcers. Int. Wound J. 2009, 6, 453–462. [Google Scholar] [CrossRef] [PubMed]
- Gottrup, F.; Apelqvist, J.; Bjarnsholt, T.; Cooper, R.; Moore, Z.; Peters, E.; Probst, S. EWMA Document: Antimicrobials and Non-healing Wounds-Evidence, Controversies and Suggestions. J. Wound Care 2013, 22 (Suppl. 5), S1–S89. [Google Scholar] [CrossRef] [PubMed]
- Halbert, A.R.; Stacey, M.C.; Rohr, J.B.; Jopp-McKay, A. The effect of bacterial colonization on venous ulcer healing. Australas. J. Dermatol. 1992, 33, 75–80. [Google Scholar] [CrossRef] [PubMed]
- Harries, R.L.; Bosanquet, D.C.; Harding, K.G. Wound bed preparation: TIME for an update. Int. Wound J. 2016, 13 (Suppl. 3), 8–14. [Google Scholar] [CrossRef] [PubMed]
- Robson, M.C.; Stenberg, B.D.; Heggers, J.P. Wound healing alterations caused by infection. Clin. Plast. Surg. 1990, 17, 485–492. [Google Scholar] [CrossRef]
- Bui, U.T.; Finlayson, K.; Edwards, H. The diagnosis of infection in chronic leg ulcers: A narrative review on clinical practice. Int. Wound J. 2019, 16, 601–620. [Google Scholar] [CrossRef] [PubMed]
- Ramelet, A.A.; Perrenoud, D. Bacteriology of leg ulcers. Curr. Probl. Dermatol. 1999, 27, 20–25. [Google Scholar] [CrossRef] [PubMed]
- Gilchrist, B.; Reed, C. The bacteriology of chronic venous ulcers treated with occlusive hydrocolloid dressings. Br. J. Dermatol. 1989, 121, 337–344. [Google Scholar] [CrossRef] [PubMed]
- Strohal, R.; Mittlböck, M.; Hämmerle, G. The Management of Critically Colonized and Locally Infected Leg Ulcers with an Acid-Oxidizing Solution: A Pilot Study. Adv. Skin Wound Care 2018, 31, 163–171. [Google Scholar] [CrossRef] [Green Version]
- Alinovi, A.; Bassissi, P.; Pini, M. Systemic administration of antibiotics in the management of venous ulcers. Randomized Clin. Trial. J. Am. Acad. Dermatol. 1986, 15, 186–191. [Google Scholar] [CrossRef]
- Mertz, P.M.; Eaglstein, W.H. The effect of a semiocclusive dressing on the microbial population in superficial wounds. Arch. Surg. 1984, 119, 287–289. [Google Scholar] [CrossRef]
- Cutting, K.; Harding, K.G. Criteria for identifying wound infection. J. Wound Care 1994, 3, 198–201. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rondas, A.A.L.M.; Schols, J.M.G.A.; Stobbering, E.E.; Price, P.E. Definition of infection in chronic wounds by Dutch nursing home physicians. Int. Wound J. 2009, 6, 267–274. [Google Scholar] [CrossRef] [PubMed]
- Dos Santos, S.L.V.; Martins, M.A.; do Prado, M.A.; Soriano, J.V.; Bachion, M.M. Are there clinical signs and symptoms of infection to indicate the presence of multidrug-resistant bacteria in venous ulcers? J. Vasc. Nurs. 2017, 35, 178–186. [Google Scholar] [CrossRef] [PubMed]
- Libby, P.; Loscalzo, J.; Ridker, P.M.; Farkouh, M.E.; Hsue, P.Y.; Fuster, V.; Hasan, A.A.; Amar, S. Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. J. Am. Coll. Cardiol. 2018, 72, 2071–2078. [Google Scholar] [CrossRef] [PubMed]
- Pawar, A.M.; LaPlante, K.L.; Timbrook, T.T.; Caffrey, A.R. Improved survival with continuation of statins in bacteremic patients. SAGE Open Med. 2018, 6, 2050312118801707. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kayani, W.T.; Bandeali, S.J.; Lee, V.-V.; Elayda, M.; Khan, A.; Nambi, V.; Jneid, H.; Alam, M.; Wilson, J.M.; Huang, H.D.; et al. Association between statins and infections after coronary artery bypass grafting. Int. J. Cardiol. 2013, 168, 117–120. [Google Scholar] [CrossRef] [PubMed]
- McDowell, S.A.; Ma, Y.; Kusano, R.; Akinbi, H.T. Simvastatin is protective during Staphylococcus aureus pneumonia. Curr. Pharm. Biotechnol. 2011, 12, 1455–1462. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nassaji, M.; Ghorbani, R.; Afshar, R.K. The Effect of Statins Use on the Risk and Outcome of Acute Bacterial Infections in Adult Patients. J. Clin. Diagn. Res. 2015, 9, OC09–OC12. [Google Scholar] [CrossRef] [PubMed]
- Pan, W.; Pintar, T.; Anton, J.; Vei-Vei, L.; Vaughn, W.K.; Collard, C.D. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004, 110 (Suppl. 1), II45–II49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Parameter | Value |
---|---|
Women | n = 485 (64.3%) |
Mean (±SD) age (years) | 65.7 ± 12.09 |
Age > 65 years | n = 415 (55.0%) |
Median (range) duration of underlying disease (years) | 24 (0–70) |
Underlying disease > 20 years | n = 392 (52.0%) |
Median (range) duration of current ulcer (months) | 12 (1–504) |
Duration of current ulcer > 12 months | n = 296 (39.3%) |
Comorbidities | n = 647 (85.8%) |
Rheumatoid arthritis | n = 118 (15.6%) |
Arthritis | n = 234 (31.0%) |
Diabetes mellitus | n = 160 (21.2%) |
Atherosclerosis 1 | n = 96 (12.7%) |
Cardiovascular disease 2 | n = 184 (24.4%) |
Overweight/obesity (BMI ≥ 25 kg/m2) | n = 633 (84.0%) |
Obesity (BMI ≥ 30 kg/m2) | n = 354 (46.9%) |
Medial ulceration | n = 469 (62.2%) |
Posterior ulceration | n = 121 (16.0%) |
Anterior ulceration | n = 129 (17.1%) |
Lateral ulceration | n = 216 (28.6%) |
Circumferential ulceration | n = 24 (3.2%) |
Posterior/circumferential ulceration | n = 141 (18.7%) |
Ulcer locations ≥ 3 | n = 58 (7.7%) |
Multiple ulcerations | n = 357 (47.3%) |
Deep ulceration | n = 659 (87.4%) |
Median (range) ulceration area at the baseline (cm2) | 8.25 (0.12–538) |
Baseline ulceration area > 8.25 cm2 | n = 373 (49.5%) |
Purulence/abscess | n = 40 (5.3%) |
Unpleasant odor | n = 103 (13.7%) |
Redness | n = 472 (62.6%) |
Swelling | n = 124 (16.4%) |
Warmth | n = 369 (48.9%) |
Pain | n = 646 (85.7%) |
Variable | Ulcer Culture | OR | (−) 95% CI | (+) 95% CI | p | |
---|---|---|---|---|---|---|
Positive | Negative | |||||
Age > 65 years | 364 (87.7%) | 272 (80.2%) | 1.76 | 1.18 | 2.61 | 0.005 |
Female sex | 419 (86.4%) | 217 (80.7%) | 1.52 | 1.02 | 2.27 | 0.039 |
Underlying disease > 20 years | 330 (84.2%) | 306 (84.5%) | 0.97 | 0.66 | 1.44 | 0.896 |
Current ulcer > 12 months | 270 (91.2%) | 366 (79.9%) | 2.61 | 1.64 | 4.15 | <0.001 |
Rheumatoid arthritis | 105 (89.0%) | 531 (83.5%) | 1.60 | 0.87 | 2.95 | 0.134 |
Arthritis | 193 (82.8%) | 443 (85.0%) | 0.85 | 0.56 | 1.29 | 0.443 |
Diabetes mellitus | 135 (84.4%) | 501 (84.3%) | 1.00 | 0.62 | 1.62 | 0.992 |
Atherosclerosis | 72 (75.0%) | 564 (85.7%) | 0.50 | 0.30 | 0.83 | 0.008 |
Allergy | 11 (73.3%) | 625 (84.6%) | 0.59 | 0.20 | 1.73 | 0.336 |
Cardiovascular disease | 152 (82.6%) | 484 (84.9%) | 0.84 | 0.54 | 1.32 | 0.455 |
Kidney disease | 6 (66.7%) | 630 (84.6%) | 0.37 | 0.09 | 1.48 | 0.158 |
Liver disease | 4 (100.0%) | 632 (84.3%) | not applicable | |||
Comorbidities | 546 (84.4%) | 90 (84.1%) | 1.02 | 0.58 | 1.79 | 0.942 |
Multiple comorbidities | 127 (78.9%) | 509 (85.8%) | 0.62 | 0.40 | 0.96 | 0.032 |
Overweight/obesity | 538 (85.0%) | 98 (81.0%) | 1.33 | 0.80 | 2.20 | 0.268 |
Obesity | 293 (82.8%) | 343 (85.7%) | 0.80 | 0.54 | 1.18 | 0.261 |
Medial ulceration | 382 (83.4%) | 246 (86.0%) | 0.82 | 0.54 | 1.24 | 0.341 |
Posterior ulceration | 105 (87.5%) | 523 (83.8%) | 1.35 | 0.76 | 2.42 | 0.31 |
Anterior ulceration | 112 (87.5%) | 516 (83.8%) | 1.36 | 0.77 | 2.39 | 0.291 |
Lateral ulceration | 188 (87.0%) | 440 (83.3%) | 1.34 | 0.85 | 2.12 | 0.207 |
Circumferential ulceration | 22 (91.7%) | 606 (84.2%) | 2.07 | 0.48 | 8.92 | 0.329 |
Deep ulceration | 564 (85.6%) | 64 (75.3%) | 1.95 | 1.14 | 3.34 | 0.015 |
Multiple ulcers | 309 (86.8%) | 325 (82.1%) | 1.44 | 0.96 | 2.14 | 0.076 |
Purulence/abscess | 40 (100.0%) | 596 (83.5%) | not applicable | |||
Unpleasant odor | 103 (100.0%) | 533 (81.9%) | not applicable | |||
Redness | 404 (85.6%) | 230 (82.1%) | 1.29 | 0.87 | 1.93 | 0.209 |
Swelling | 115 (92.7%) | 521 (82.7%) | 2.67 | 1.32 | 5.43 | 0.007 |
Warmth | 313 (84.8%) | 321 (83.8%) | 1.08 | 0.73 | 1.60 | 0.703 |
Pain | 545 (84.5%) | 90 (83.3%) | 1.10 | 0.64 | 1.90 | 0.722 |
Ulceration area > 8.25 cm2 | 331 (88.7%) | 305 (80.0%) | 1.96 | 1.31 | 2.95 | 0.001 |
Variable | OR | (−) 95% CI | (+) 95% CI | p |
---|---|---|---|---|
With the signs of infection | ||||
Age > 65 years | 1.78 | 1.17 | 2.70 | 0.007 |
Female sex | 1.46 | 0.96 | 2.23 | 0.076 |
Current ulcer > 12 months | 2.27 | 1.40 | 3.67 | 0.001 |
Atherosclerosis | 0.46 | 0.24 | 0.88 | 0.019 |
Multiple comorbidities | 0.92 | 0.52 | 1.60 | 0.759 |
Deep ulceration | 1.61 | 0.92 | 2.84 | 0.097 |
Multiple ulcers | 1.07 | 0.70 | 1.65 | 0.747 |
Swelling | 2.02 | 0.93 | 4.36 | 0.075 |
Ulceration area > 8.25 cm2 | 1.39 | 0.88 | 2.21 | 0.158 |
Without the signs of infection | ||||
Age > 65 years | 1.75 | 1.15 | 2.65 | 0.009 |
Female sex | 1.46 | 0.96 | 2.22 | 0.080 |
Current ulcer > 12 months | 2.35 | 1.45 | 3.79 | <0.001 |
Atherosclerosis | 0.49 | 0.26 | 0.93 | 0.028 |
Multiple comorbidities | 0.92 | 0.53 | 1.60 | 0.761 |
Deep ulceration | 1.66 | 0.94 | 2.92 | 0.078 |
Multiple ulcers | 1.09 | 0.71 | 1.69 | 0.683 |
Ulceration area > 8.25 cm2 | 1.61 | 1.04 | 2.51 | 0.034 |
Variable | Alert Pathogens | OR | (−) 95% CI | (+) 95% CI | p | |
---|---|---|---|---|---|---|
Yes | No | |||||
Age > 65 years | 104 (25.1%) | 78 (23.0%) | 1.12 | 0.80 | 1.57 | 0.501 |
Female sex | 111 (22.9%) | 71 (26.4%) | 0.83 | 0.59 | 1.17 | 0.288 |
Underlying disease > 20 years | 99 (25.3%) | 83 (22.9%) | 1.14 | 0.82 | 1.59 | 0.444 |
Current ulcer > 12 months | 100 (33.9%) | 82 (17.9%) | 2.35 | 1.67 | 3.30 | <0.001 |
Rheumatoid arthritis | 35 (29.7%) | 147 (23.1%) | 1.40 | 0.91 | 2.16 | 0.130 |
Arthritis | 62 (26.6%) | 120 (23.1%) | 1.21 | 0.85 | 1.72 | 0.296 |
Diabetes mellitus | 35 (21.9%) | 147. (24.8%) | 0.85 | 0.56 | 1.29 | 0.445 |
Atherosclerosis | 18 (18.7%) | 164 (25.0%) | 0.69 | 0.40 | 1.19 | 0.186 |
Allergy | 6 (40.0%) | 176 (23.8%) | 2.13 | 0.75 | 6.06 | 0.157 |
Cardiovascular disease | 40 (21.7%) | 142 (25.0%) | 0.84 | 0.56 | 1.24 | 0.376 |
Kidney disease | 4 (44.4%) | 178 (23.9%) | 2.54 | 0.68 | 9.58 | 0.167 |
Liver disease | 2 (50.0%) | 180 (24.0%) | 3.16 | 0.44 | 22.60 | 0.251 |
Comorbidities | 156 (24.1%) | 26 (24.3%) | 0.99 | 0.62 | 1.60 | 0.973 |
Multiple comorbidities | 40 (24.8%) | 142 (24.0%) | 1.05 | 0.70 | 1.57 | 0.822 |
Overweight/obesity | 156 (24.6%) | 26 (21.7%) | 1.18 | 0.74 | 1.89 | 0.485 |
Obesity | 94 (26.5%) | 88 (22.1%) | 1.28 | 0.91 | 1.78 | 0.151 |
Medial ulceration | 117 (25.6%) | 63 (22.0%) | 1.22 | 0.86 | 1.73 | 0.269 |
Posterior ulceration | 29 (24.2%) | 151 (24.2%) | 1.00 | 0.63 | 1.57 | 0.987 |
Anterior ulceration | 34 (26.6%) | 146 (23.7%) | 1.16 | 0.75 | 1.79 | 0.498 |
Lateral ulceration | 48 (22.2%) | 132 (25.0%) | 0.85 | 0.59 | 1.25 | 0.415 |
Circumferential ulceration | 9 (37.5%) | 171 (23.8%) | 1.92 | 0.83 | 4.47 | 0.129 |
Deep ulceration | 165 (25.0%) | 15 (17.9%) | 1.54 | 0.86 | 2.76 | 0.151 |
Multiple ulcers | 91 (25.6%) | 91 (23.0%) | 1.15 | 0.82 | 1.60 | 0.420 |
Purulence/abscess | 34 (85.0%) | 148 (20.8%) | 21.63 | 8.91 | 52.50 | <0.001 |
Unpleasant odor | 96 (93.2%) | 86 (13.2%) | 89.94 | 40.41 | 200.20 | <0.001 |
Redness | 113 (23.9%) | 69 (24.7%) | 0.96 | 0.68 | 1.35 | 0.807 |
Swelling | 49 (39.5%) | 133 (21.1%) | 2.44 | 1.62 | 3.66 | <0.001 |
Warmth | 81 (21.9%) | 101 (26.4%) | 0.78 | 0.56 | 1.09 | 0.152 |
Pain | 162 (25.2%) | 20 (18.5%) | 1.44 | 0.87 | 2.40 | 0.159 |
Ulceration area > 8.25 cm2 | 121 (32.4%) | 61 (16.0%) | 2.51 | 1.77 | 3.56 | <0.001 |
Variable | OR | (−) 95% CI | (+) 95% CI | p |
---|---|---|---|---|
With the signs of infection | ||||
Current ulcer > 12 months | 1.50 | 0.93 | 2.42 | 0.095 |
Purulence/abscess | 22.82 | 8.53 | 61.05 | <0.001 |
Unpleasant odor | 84.55 | 37.06 | 192.86 | <0.001 |
Swelling | 0.82 | 0.41 | 1.63 | 0.569 |
Ulceration area > 8.25 cm2 | 1.22 | 0.74 | 2.01 | 0.441 |
Without the signs of infection | ||||
Current ulcer > 12 months | 2.02 | 1.43 | 2.87 | <0.001 |
Ulceration area > 8.25 cm2 | 2.19 | 1.53 | 3.14 | <0.001 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cwajda-Białasik, J.; Mościcka, P.; Jawień, A.; Szewczyk, M.T. Microbiological Status of Venous Leg Ulcers and Its Predictors: A Single-Center Cross-Sectional Study. Int. J. Environ. Res. Public Health 2021, 18, 12965. https://doi.org/10.3390/ijerph182412965
Cwajda-Białasik J, Mościcka P, Jawień A, Szewczyk MT. Microbiological Status of Venous Leg Ulcers and Its Predictors: A Single-Center Cross-Sectional Study. International Journal of Environmental Research and Public Health. 2021; 18(24):12965. https://doi.org/10.3390/ijerph182412965
Chicago/Turabian StyleCwajda-Białasik, Justyna, Paulina Mościcka, Arkadiusz Jawień, and Maria Teresa Szewczyk. 2021. "Microbiological Status of Venous Leg Ulcers and Its Predictors: A Single-Center Cross-Sectional Study" International Journal of Environmental Research and Public Health 18, no. 24: 12965. https://doi.org/10.3390/ijerph182412965
APA StyleCwajda-Białasik, J., Mościcka, P., Jawień, A., & Szewczyk, M. T. (2021). Microbiological Status of Venous Leg Ulcers and Its Predictors: A Single-Center Cross-Sectional Study. International Journal of Environmental Research and Public Health, 18(24), 12965. https://doi.org/10.3390/ijerph182412965